Insulet (Nasdaq:PODD) announced that it successfully defended its intellectual property against EOFlow in U.S. federal court.
A London scientist is working on the world’s first oral insulin patch that could save diabetes patients from having to regularly inject the drug. Dr Hend Abdelhakim, an assistant professor at ...
Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...
The Massachusetts district court awarded Insulet a total of $452 million, including $170 million in compensation plus $282 ...
Embecta (Nasdaq:EMBC) filed with the state of Massachusetts to confirm a workforce reduction affecting 118 employees.
Insulet Corp. wins $452M against EOFlow for trade secrets theft in a wearable insulin pump dispute. Learn more about the ...
Medical device maker Insulet convinced a jury that Korean rival EOFlow owes it $452 million in damages for stealing trade ...
we have decided to discontinue our insulin patch pump program and initiate an organizational restructuring plan. We believe this approach will streamline operations, reduce costs and enhance our ...
CEO Dev Kurdikar said the decision may “come as a surprise” as Embecta just received FDA clearance for a patch pump, but the ...
Insulet Corp., a Massachusetts-based medical device company, secured a staggering $452 million jury verdict against South ...
Embecta Corp.'s Q4 results showed significant net income and EPS growth. Embecta also announced a restructuring plan. See why ...